<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Bulgaria</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Bulgaria.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/bg.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Salmonellosis Outbreak in a Rottweiler Kennel Associated with Raw Meat-Based Diets</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-ani15213196-3b97057c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-ani15213196-3b97057c/</guid>
    <pubDate>Mon, 03 Nov 2025 00:00:00 GMT</pubDate>
    <description>The report highlights the cross-species transmission potential of pathogens found in unregulated raw animal feed. It advocates for enhanced feed traceability and biosecurity standards to mitigate health threats under a collaborative veterinary-human health approach.</description>
    <category>Salmonellosis</category>
    <category>Outbreak investigation</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Climate and environment</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-24-00143-9-c153178e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-24-00143-9-c153178e/</guid>
    <pubDate>Thu, 01 Aug 2024 00:00:00 GMT</pubDate>
    <description>The paper provides context for tuberculosis vaccine development by describing a controlled human infection model intended for future evaluation of vaccine efficacy and potential correlates of protection. It does not provide evidence about population-level tuberculosis surveillance or current disease activity.</description>
    <category>Tuberculosis</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Vaccine effectiveness</category>
    <category>Randomised controlled trial</category>
  </item>
</channel>
</rss>
